UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 189

Sortiert nach

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Annals of oncology, 2023-04, Vol.34 (4), p.339-357

2023

Volltextzugriff (PDF)

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Annals of oncology, 2023-04, Vol.34 (4), p.358-376

2023

Volltextzugriff (PDF)

New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response

European respiratory review, 2014-09, Vol.23 (133), p.367-378

2014

Volltextzugriff (PDF)

Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

Critical reviews in oncology/hematology, 2020-02, Vol.146, p.102858-102858, Article 102858

2020

Volltextzugriff (PDF)

Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

Critical reviews in oncology/hematology, 2020-04, Vol.148, p.102862-102862, Article 102862

2020

Volltextzugriff (PDF)

Long-term update of the 24954 EORTC phase III trial on larynx preservation

European journal of cancer (1990), 2016-09, Vol.65, p.109-112

2016

Volltextzugriff (PDF)

YI02.02 Basket and Umbrella Trial Designs in Oncology

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S1119-S1119

Menis, J.

2019

Volltextzugriff (PDF)

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

Annals of oncology, 2018-04, Vol.29 (4), p.985-991

2018

Volltextzugriff (PDF)

3023 Pan-European survey on thymic malignancies: A collaboration of the EORTC Lung Cancer Group (LCG) with the RYTHMIC network

European journal of cancer (1990), 2015-09, Vol.51, p.S604-S604

2015

Volltextzugriff (PDF)

TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial

Annals of oncology, 2017-09, Vol.28 (9), p.2219-2224

2017

Volltextzugriff (PDF)

Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer

Breast cancer targets and therapy, 2011-08, Vol.3 (default), p.101-111

2011

Volltextzugriff (PDF)

Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer

The pharmacogenomics journal, 2019-02, Vol.19 (1), p.15-24

2019

Volltextzugriff (PDF)

Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study

Annals of oncology, 2017-09, Vol.28 (9), p.2213-2218

2017

Volltextzugriff (PDF)

Molecular profile characterization and impact on clinical outcome in metastatic NSCLC patients enrolled in MOSCATO 01 trial

Annals of oncology, 2017-10, Vol.28, p.vi55-vi55

2017

Volltextzugriff (PDF)

APPLE trial: Feasibility and activity of AZD9291 (osimertinib) treatment on Positive PLasma T790M in EGFR mutant NSCLC patients. EORTC 1613

Clinical lung cancer, 2017-09, Vol.18 (5), p.583-588

2017

Volltextzugriff (PDF)

3638 POSTER Integrated Care Pathways for Non Small Cell Lung Cancer (NSCLC) Patients: Avoidable Costs Analysis in a Quality Improvement Project

European journal of cancer (1990), 2011, Vol.47, p.S270-S270

2011

Volltextzugriff (PDF)

Basket and Umbrella Trial Designs in Oncology: YI02.02

Journal of thoracic oncology, 2019-10, Vol.14 (10 Suppl), p.S1119-S1119

Menis, J

2019

Volltextzugriff (PDF)

Prospects of targeted and immune therapies in SCLC

Expert review of anticancer therapy, 2019-02, Vol.19 (2), p.151-167

2019

Volltextzugriff (PDF)

1857P Choose health, oncological patients centered exercise (CHOiCE): Preliminary findings of a pilot randomized controlled trial

Annals of oncology, 2021-09, Vol.32, p.S1249-S1250

2021

Volltextzugriff (PDF)

1618P Impact of body composition phenotypes on outcome of non-small cell lung cancer patients treated with immunotherapy

Annals of oncology, 2022-09, Vol.33, p.S1281-S1282

2022

Volltextzugriff (PDF)

1296P Immune checkpoint inhibitors with or without bone targeted therapy in NSCLC patients with bone metastases and prognostic significance of neutrophil-to-lymphocyte ratio

Annals of oncology, 2021-09, Vol.32, p.S1004-S1005

2021

Volltextzugriff (PDF)

1675P Potential effect of adipose tissue distribution on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients (pts) receiving first-line pembrolizumab (PEMBRO)

Annals of oncology, 2021-09, Vol.32, p.S1176-S1177

2021

Volltextzugriff (PDF)

1640P Impact of COVID-19 vaccination campaign on psychological status in cancer patients (pts)

Annals of oncology, 2021-09, Vol.32, p.S1159-S1159

2021

Volltextzugriff (PDF)

119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts)

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S763-S763

2021

Volltextzugriff (PDF)

181P Multicenter real-world study (RWS) on efficacy and early discontinuation predictors in non-small cell lung cancer (NSCLC) patients (pts) receiving nivolumab

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S796-S796

2021

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(175)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response

Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

Long-term update of the 24954 EORTC phase III trial on larynx preservation

YI02.02 Basket and Umbrella Trial Designs in Oncology

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

3023 Pan-European survey on thymic malignancies: A collaboration of the EORTC Lung Cancer Group (LCG) with the RYTHMIC network

TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial

Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer

Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer

Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study

Molecular profile characterization and impact on clinical outcome in metastatic NSCLC patients enrolled in MOSCATO 01 trial

APPLE trial: Feasibility and activity of AZD9291 (osimertinib) treatment on Positive PLasma T790M in EGFR mutant NSCLC patients. EORTC 1613

3638 POSTER Integrated Care Pathways for Non Small Cell Lung Cancer (NSCLC) Patients: Avoidable Costs Analysis in a Quality Improvement Project

Basket and Umbrella Trial Designs in Oncology: YI02.02

Prospects of targeted and immune therapies in SCLC

1857P Choose health, oncological patients centered exercise (CHOiCE): Preliminary findings of a pilot randomized controlled trial

1618P Impact of body composition phenotypes on outcome of non-small cell lung cancer patients treated with immunotherapy

1296P Immune checkpoint inhibitors with or without bone targeted therapy in NSCLC patients with bone metastases and prognostic significance of neutrophil-to-lymphocyte ratio

1675P Potential effect of adipose tissue distribution on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients (pts) receiving first-line pembrolizumab (PEMBRO)

1640P Impact of COVID-19 vaccination campaign on psychological status in cancer patients (pts)

119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts)

181P Multicenter real-world study (RWS) on efficacy and early discontinuation predictors in non-small cell lung cancer (NSCLC) patients (pts) receiving nivolumab

Suchergebnisse filtern